TRILOGY 2281 patients randomized 2.5:1. CaPre dosed would be 200 and placebo 81. The five problem sites represent 12% or 33 patients. If randomized as stated that would be 24 CaPre and 9 placebo. There are 81 total placebo so getting to a median number where it needs to be seems attainable and likely